
Keywords: Ab; antibody; DLQI; dermatology quality of life index; LCN2; lipocalin 2; NGAL; neutrophil gelatinase-associated lipocalin; PBMC; peripheral blood mononuclear cells; PPP; palmoplantar pustular psoriasis; PV; psoriasis vulgaris; Skin inflammation; Biomarke